Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Return on Sales (2016 - 2025)

Conmed's Return on Sales history spans 16 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Sales fell 5.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.03%, down 7.0%, while the annual FY2025 figure was 0.03%, 7.0% down from the prior year.
  • Return on Sales reached 0.04% in Q4 2025 per CNMD's latest filing, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.17% in Q3 2022 to a low of 0.61% in Q2 2022.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.06% recorded in 2021.
  • Peak YoY movement for Return on Sales: plummeted -66bps in 2022, then skyrocketed 65bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.09% in 2021, then rose by 19bps to 0.11% in 2022, then fell by -5bps to 0.1% in 2023, then fell by -4bps to 0.1% in 2024, then plummeted by -54bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Return on Sales are 0.04% (Q4 2025), 0.01% (Q3 2025), and 0.06% (Q2 2025).